Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Researchers compared RL-007 (Inidascamine) and placebo to find out how the approaches affected memory, attention and other thinking skills in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Culver CityA Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
This study has finished and is no longer accepting participants.
Multiple locations, including ChandlerResearchers are studying Emraclidine 30 mg, tracking side effects to assess long-term safety and tolerability in adults with schizophrenia.
This study ended early.
Multiple locations, including PhoenixThis study evaluated the safety and effectiveness of SAGE-217 for people with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study evaluated the safety and effectiveness of SAGE-547 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Atlanta
A Study to Evaluate Sleep Electroencephalogram (EEG) Features in Participants With Major Depressive Disorder (MDD)
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixA Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres
Read the official source — NCT00216528A Prospective, Open-Label Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres (Risperdal Consta)
This study has finished and is no longer accepting participants.
Location not clearly listedA Pilot-Study in Rwandan Health Care Settings to Examine the Feasibility of a Large Pragmatic Clinical Study to Assess the Value of Paliperidone Palmitate in Rwanda
This study has finished and is no longer accepting participants.
Multiple locations, including KigaliA Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users
This study has finished and is no longer accepting participants.
In Overland ParkA Randomized, Double-Blind, Placebo- and Active-Controlled, Crossover Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists in Physically Dependent Opioid Users With Moderate-to-Severe Opioid Use Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including LexingtonA Double-Blind, Cross-Over Placebo-Controlled and Active-Controlled Trial To Evaluate The Effect Of A Supratherapeutic Dose Of MK-8189 On The QTc Interval In Participants With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including GlendaleA Randomized, Open-Label, Study To Evaluate The Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Selected Cognitive Domains in Clinically Stable Subjects With Schizophrenia
This study ended early.
Multiple locations, including Bali Township, Taipei CountyWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.